Pediatrix Medical (PDX) Reports Q2 EPS of $0.80, Beats by 2c
More News related to PDX
- Pediatrix Medical Name Change to MEDNAX Effective Today
- Pediatrix Medical (PDX) Acquires Tampa Bay Maternal Fetal Group Practice
- Wasserman Initiates Coverage on Pediatrix Medical Group (PDX) with a Buy
- Pediatrix Medical (PDX) Reports In-Line Q3; Guides
- Citi Maintains 'Buy' on Pediatrix Medical Group (PDX), Drops Price Target
Pediatrix Medical Group, Inc. (NYSE: PDX) reports Q2 EPS of $0.80, 2 cents better than the analyst estimate of $0.78. Revenues for the quarter were $223.26 million on a non-GAAP basis, versus the consensus of $248.51 million.
Pediatrix Medical Group, Inc. provides neonatal, maternal-fetal, other pediatric subspecialty, and anesthesia physician services in the United States and Puerto Rico.
Related Categories
EarningsStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
